Reuters logo
BRIEF-Probiodrug Q3 ‍Loss Shrinks To EUR 1.7 Mln
November 30, 2017 / 6:08 AM / 19 days ago

BRIEF-Probiodrug Q3 ‍Loss Shrinks To EUR 1.7 Mln

Nov 30 (Reuters) - Probiodrug AG:

* REG-PROBIODRUG AG: PROBIODRUG REPORTS THIRD QUARTER 2017 BUSINESS UPDATE

* RESEARCH AND DEVELOPMENT EXPENSES IN Q3 WERE EUR 1,127K, LOWER THAN CORRESPONDING NUMBERS IN 2016 (EUR 1,776K)​

* ‍DID NOT GENERATE ANY REVENUE IN Q3 OF 2017​

* Q3 ‍LOSS IS EUR 1,656K IN Q3 OF 2017, COMPARED TO EUR 2,383K IN Q3 OF 2016​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below